Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRT

NCT06088862 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped BIDI product received a market denial letter from the FDA

Conditions

Smoking Cessation
Harm Reduction

Interventions

DRUG: Nicoderm
DRUG: Nicorette 4Mg Chewing Gum
DRUG: Nicorette Lozenge Product
OTHER: BIDI e-cigarette
OTHER: on!

Sponsor

Rose Research Center, LLC

Collaborators

[object Object]